Food giants weaponize lawsuits to block health rules

The observation of the ultra-processed food manufacturer engaging in litigation against public health regulators presents a curious inversion of the typical industrial relationship. In the ordinary course of business enterprise, the firm seeks to minimize the friction of compliance; here, the firm actively cultivates friction, not to avoid regulation, but to exhaust the regulatory apparatus itself. One is witnessing a ritual of obfuscation, wherein the legal process serves not as a mechanism for justice, but as a ceremonial display of corporate stamina. The outcome of these suits is secondary to the spectacle of the suit itself, which functions to signal to the market that the enterprise is sufficiently powerful to delay the inevitable.

Since 2010, this phenomenon has taken root in five distinct national jurisdictions, suggesting a coordinated, if unspoken, strategy among the largest producers of engineered edibles. The stated purpose of these lawsuits is often framed as the protection of intellectual property or the prevention of overreach, yet the structural mapping reveals a different objective. The ceremonial function of the litigation is to create a zone of uncertainty where health guidelines cannot solidify into law. By keeping the regulatory environment in a state of perpetual contestation, the leisure class of the food industry ensures that the consumer remains in a state of confusion, unable to distinguish between nutritional necessity and marketing suggestion.

Consider the mechanism of the “revolving door” between the regulatory bodies and the boardrooms of these conglomerates. It is not merely a matter of personnel moving from one office to another; it is a circulation of incentives that aligns the interests of the regulator with those of the regulated. The former official, now a consultant or lobbyist, brings with him not only insider knowledge but a ceremonial loyalty to the institution that employed him. This loyalty is not personal; it is structural. The institution does not care who holds the office, only that the office remains occupied by someone who understands the ceremonial value of delay. The litigation, therefore, is a tool of this alignment, a way to remind the government that the cost of enforcement is borne by the taxpayer, while the benefit of delay is retained by the shareholder.

The stakes are high, yet the mechanism is subtle. The public health policies designed to limit the consumption of ultra-processed foods are framed as intrusive restrictions on choice. The industry, in turn, frames its litigation as a defense of liberty. But this is a false dichotomy. The choice is not between regulation and freedom; it is between a market that externalizes the costs of poor health and a market that internalizes them. The litigation serves to externalize these costs, shifting the burden of proof from the producer to the public. The consumer, armed with conflicting labels and delayed warnings, is left to navigate a landscape of engineered cravings with little guidance.

One might argue that this is simply aggressive advocacy, a normal part of the political process. But the scale and coordination of these efforts across five countries suggest something more systematic. The industry is not merely lobbying; it is litigating to create a precedent of inertia. Each lawsuit, regardless of its merit, serves to reinforce the idea that health regulations are burdensome, expensive, and subject to challenge. This is a ceremonial display of power, akin to a potlatch where the host destroys wealth to demonstrate superiority. Here, the wealth destroyed is not gold or goods, but public trust and administrative efficiency.

The anthropological observer, unfamiliar with the customs of this civilisation, would conclude that the primary function of these lawsuits is not to win cases, but to lose them slowly. The delay is the victory. The exhaustion of the regulatory body is the goal. The health of the consumer is irrelevant to this ritual, except as the object upon which the ritual is performed. The industry does not seek to prove that ultra-processed foods are healthy; it seeks to prove that the government cannot prove they are not. In this light, the litigation is not a legal strategy, but a ceremonial one, designed to maintain the status of the leisure class by keeping the productive functions of the state in a state of suspended animation.

The final image is not of a courtroom, but of a boardroom, where executives watch the calendar turn, knowing that time is their ally. They do not need to win; they only need to wait. The health of the population is a long-term liability, while the quarterly dividend is a short-term certainty. In this calculus, the lawsuit is not a risk, but an investment, one that pays dividends in the form of delayed regulation and maintained market dominance. The ritual continues, not because it is effective, but because it is profitable.